
Small molecule protein inhibition with Interdict Bio
2026-06-14
0:00
29:48
In today's episode we are joined by Dr Lawrence Hamann from Interdict Bio! We hear about bioavailable small molecule drugs that can inhibit ribosomal protein synthesis in MYC-dependent cancers. We also learn some tips for people looking to get into a drug development career!
Fler avsnitt från "Dangerous Ideas In Drug Development"



Missa inte ett avsnitt av “Dangerous Ideas In Drug Development” och prenumerera på det i GetPodcast-appen.








